












One fundamental issue in development is to understand how cells
adopt different fates that lead to their own unique properties. This
question becomes more challenging to understand when such cells
are adjacent and originate from common ancestral cells. Notch-
Delta/Serrate signaling mediates cell-cell interactions of
neighboring cells to specify their fates in metazoan development and
its dysfunction results in various developmental defects and disease
pathologies (Garg et al., 2005; Weng and Aster, 2004; Yoon and
Gaiano, 2005).
Specification of the C. elegans anchor cell (AC) and ventral
uterine precursor (VU) cell fates, initiated by the interaction between
ligand LAG-2 (Delta) and receptor LIN-12 (Notch), is a model
system to understand the molecular mechanisms through which the
Notch signaling pathway specifies the fates of neighboring cells
(Lambie and Kimble, 1991; Seydoux and Greenwald, 1989;
Wilkinson et al., 1994). In wild-type animals, LIN-12 signaling is
necessary for the two somatic gonadal cells [Z1.ppa and Z4.aap;
presumptive-VU (pre-VU) cells] to become VU cells. Their sister
cells (Z1.ppp and Z4.aaa) have equal potential to become AC or VU
cells (Seydoux and Greenwald, 1989; Wilkinson et al., 1994). After
AC/VU specification, one of them expresses only LAG-2 and adopts
the AC fate, and the other expresses only LIN-12 and becomes a VU
cell (Seydoux and Greenwald, 1989; Wilkinson et al., 1994). lin-12
expression appears to be maintained in the VU cells by a positive-
feedback loop that is not well understood. The mechanism that
results in the exclusive expression of LAG-2 in the AC appears to
involve post-transcriptional downregulation of HLH-2, the C.
elegans ortholog of mammalian E12/E47 and D. melanogaster
Daughterless (Karp and Greenwald, 2003). The hlh-2 gene is
transcribed in the pre-AC/pre-VU, AC and VU cells, but its encoded
protein is absent in the VU cells (Karp and Greenwald, 2003; Karp
and Greenwald, 2004). As HLH-2 is required for lag-2 transcription,
the absence of HLH-2 protein appears to be responsible for the
elimination of lag-2 transcription in the VU cells (Karp and
Greenwald, 2003).
The distinct cellular properties of the AC and VU cells suggest
that they can be used not only to study the mechanisms of Notch-
dependent cell fate specification, but also to understand how a cell
fate decision is coupled to the later-stage differentiation events. The
VU cells undergo four rounds of cell division (Kimble and Hirsh,
1979; Newman et al., 1996), whereas the AC remains a single cell
in the gonad and expresses LIN-3, an epidermal growth factor (EGF)
that induces proliferation of vulval precursor cells (VPCs) (Hill and
Sternberg, 1992). We previously identified a 59 bp lin-3 enhancer
element sufficient to activate lin-3 transcription solely in the AC.
This element consists of two E-boxes and one FTZ-F1 nuclear
hormone receptor (NHR) binding site (Hwang and Sternberg, 2004).
HLH-2 binds to the E-boxes and is necessary for lin-3 transcription
in the AC (Hwang and Sternberg, 2004). The AC also invades the
vulval epithelium by extending a process toward the 1° lineage
(P6.p) of vulval cells (Sherwood and Sternberg, 2003). The
destruction of the underlying basement membranes during AC
invasion requires FOS-1, a C. elegans homolog of the proto-
oncogene Fos, as well as the metalloproteinase ZMP-1 and the
fibulin HIM-4 (Sherwood et al., 2005).
Genetic screens have identified proteins that modify LIN-12
activity but no physiologically relevant downstream targets
involved in AC/VU specification (Greenwald, 2005; Kimble and
Simpson, 1997), which might be due to redundancy or pleiotropy
of such targets. In this study, we took a bioinformatics-based
approach to identify the LIN-12 downstream targets involved in
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AC/VU specification. We first developed a computational
program (ClusterSearch) to carry out a genome-wide
computational search for genes co-expressed from a common
regulatory element consisting of multiple binding sites of
sequence-specific DNA-binding proteins. The program identifies
orthologous genes sharing a defined regulatory element in the
annotated genome sequences of C. elegans and C. briggsae. Using
this program we identified egl-43 as a gene co-expressed with lin-
3 during AC/VU specification. EGL-43, which is the C. elegans
ortholog of the EVI1 proto-oncogene that has a sequence-specific
DNA-binding activity and acts as a transcriptional repressor, is
involved in AC/VU specification as a direct target of LIN-12 and
HLH-2. EGL-43 regulates FOS-1-dependent basement membrane
breakdown during AC invasion. Characterization of the egl-43
regulatory region indicates that the C. elegans orthologs of a set
of genes involved in cancer (E12/E47, EGF, EVI1, Fos and Notch)
interact to coordinate early-stage AC/VU cell fate decision as well
as late-stage events of vulval induction and anchor cell invasion.
MATERIALS AND METHODS
General methods and strains
C. elegans strains were maintained at 20°C and crossed following standard
protocols (Brenner, 1974). Cell anatomy was observed with Nomarski
optics, and CFP, GFP and YFP expression were observed using a
Hamamatsu ORCA-ER on a Zeiss Axioplan compound microscope.
Photographs were taken with a digital camera and Improvision Openlab
software, and images were overlaid using Adobe Photoshop CS.
The wild-type strain used in this study is C. elegans var. Bristol strain N2.
The following variants of N2 were used: unc-119(ed4); syIs107[lin-3(pes-
10)::GFP + pDP#MM016B], dpy-20(e1282); him-5(e1490); syIs50[cdh-
3::GFP + pMH86], dpy-20(e1282) syIs49[zmp-1::GFP + pMH86], dpy-
20(e1282); arIs50(sel-8::GFP), syIs128[lag-2::YFP + pDP#MM016B];
unc-119(ed4); him-5(e1490), syIs113[sparc::GFP + pDP#MM016B]; unc-
119(ed4), unc-119(ed4); syIs57[cdh-3::CFP + pDP#MM016B], unc-
119(ed4); syIs129[him-4::GFP + pDP#MM016B], syIs118[Ce-fos-L::YFP
+ pDP#MM016B]; unc-119(ed4), dpy-19(e1259) lin-12(n137)/unc-
32(e189) lin-12(n676n909); him-5(e1467), egl-43(n997); unc-76(e911), egl-
43(n1079), rol-6(e187)unc-4(e120)/mnC1[dpy-10(e128) unc-52(e444)];
him-5(e1490), egl-43(tm1802)/mnC1[dpy-10(e128) unc-52(e444)], unc-
119(ed4); syIs57[cdh-3::CFP + pDP#MM016B]; syEx891[egl-43(mutated
E-boxes)::YFP + myo-2::YFP], syIs57[cdh-3::CFP + pDP#MM016B];
syEx892[egl-43(mutated E-boxes)::YFP + myo-2::YFP], syIs57[cdh-
3::CFP + pDP#MM016B]; syEx895[egl-43(wild-type)::YFP + myo-
2::YFP], syIs57[cdh-3::CFP + pDP#MM016B]; syEx896[egl-43(wild-
type)::YFP + myo-2::YFP], syIs57[cdh-3::CFP + pDP#MM016B];
syEx897[egl-43(mutated LAG-1 sites)::YFP + myo-2::YFP], syIs57[cdh-
3::CFP + pDP#MM016B]; syEx898[egl-43(mutated LAG-1 sites)::YFP +
myo-2::YFP], syIs57[cdh-3::CFP + pDP#MM016B]; syEx899[egl-
43(mutated LAG-1 sites)::YFP + myo-2::YFP], syIs57[cdh-3::CFP +
pDP#MM016B]; syEx900[egl-43(mutated LAG-1 sites)::YFP + myo-
2::YFP]. Information about these alleles and transgenes can be found
through WormBase (http://www.wormbase.org).
RNAi analysis
RNA-mediated interference (RNAi) was performed by soaking
synchronized animals in dsRNA solutions as described previously (Hwang
and Sternberg, 2004; Tabara et al., 1998). RNAi soaking against the
following genes did not cause a defect in AC/VU specification: B0286.5,
C04A2.3A, C07A12.1A, C08C3.1A, C18A3.8, C27C12.2, C29E6.2,
C34B4.2, C35C5.4, C37C3.6B, C47B2.4, C55C2.1, F10E9.6C, F15D3.4,
F25D7.3, F25H2.9, F27C11.3A, F29G9.4A, F30H5.3, F43G9.11, F53B2.6,
F54D1.6, F54G8.3, F55A8.1, F55C7.7A, F57C9.4B, K02D7.2, K04H4.1A,
K08C7.3A, R07E5.3, T01E8.2, T22F7.3, T22F7.5, W02D3.12, W08D2.1,
Y34D9B.1, Y37D8A.13, Y38C1AA.9, Y38H8A.5C, Y47D3A.6A,
Y50D4C.1A, Y54E10B1.6, Y54H5A.2, Y55F3AM.14, Y75B8A.17 and
ZK783.1.
DNA binding
Electrophoretic mobility shift assays with purified HLH-2 and in vitro-
translated LAG-1 were performed as described previously (Christensen et al.,
1996; Hwang and Sternberg, 2004; Zimber-Strobl et al., 1994). The
sequences of DNA probes and competitors are summarized in Table 1.
Chromatin immunoprecipitation (ChIP) with anti-HLH-2 and anti-LAG-3
(SEL-8) antibodies were performed as described previously (Lee et al., 2006).
AC invasion analysis
AC invasion was assayed as described previously (Sherwood et al., 2005;
Sherwood and Sternberg, 2003). In brief, AC invasion was first evaluated at
mid-L3 (granddaughters of P6.p, 4-cell stage) and the L3 molt (great-
granddaughters of P6.p, 8-cell stage) using Nomarski optics. Second, the
cdh-3::GFP marker, which localizes GFP in the cytoplasm of the AC (from
late L2) and some vulval cells (from L3 molt), was used to follow the
movement and shape of the AC. In wild-type animals, the basolateral side
of the AC crosses through a hole in the basement membranes and penetrates
between central 1°-fated vulval cells beginning in mid-L3, resulting in the
overlap of cytoplasmic GFP signal in the AC with that in the vulval cells at
early L4. Third, sparc::GFP, a marker for the basement membranes of
gonadal and ventral epidermis, was used to directly measure the breakdown
of the membranes beneath the AC. In wild-type animals, these membranes
are degraded beneath the AC after the L3 molt.
Constructs and transgenic lines
The egl-43::YFP translational fusion construct (PR-domain::YFP), which
expresses YFP fused with the N-terminal domain of EGL-43 (PR-domain,
a known protein-protein interaction domain), was prepared by fusing
NLS4::YFP in-frame at the second exon of egl-43. 2874 bp of genomic
sequence of egl-43 [between 981 bp upstream (5-AGGAAACTTATTACA-
3) and 1893 bp downstream (5-GCTGATGACGGAGAA-3) of the
translational initiation site] was PCR amplified from N2 genomic DNA and
then cloned into the StuI and AscI sites in the pPD122.53(YFP) plasmid.
pPD122.53(YFP) was generated by replacing the GFP in pPD122.53
(obtained from Andy Fire, Stanford University, Palo Alto, CA) with YFP
and introducing an AscI site 5 to the nuclear localization sequence. Multiple
clones were sequenced to obtain the egl-43::YFP construct containing the
wild-type sequence. PCR fusion was used to generate site-directed mutations
of E-boxes and LAG-1 binding sites in the 5-regulatory and first intronic
regions of egl-43 (Hobert, 2002). An MluI (for mutating E-boxes) or PstI
(for mutating LAG-1 binding sites) site was introduced during the site-
directed mutagenesis but these changes did not affect the egl-43::YFP
expression pattern (data not shown). All mutations were confirmed by DNA
sequencing. The egl-43 sequence in the egl-43::YFP constructs that contain
the wild-type or mutated E-boxes or LAG-1 binding sites is shown in Fig.
S1 (see Fig. S1 in the supplementary material).
Transgenic lines for egl-43::YFP constructs were generated using a
standard microinjection protocol (Mello et al., 1991). Each YFP construct
(25 or 50 g/ml) was co-injected with pBluescript (170 g/ml) and myo-
2::YFP (5 g/ml) plasmids. After injection, transgenic animals were
identified and maintained by myo-2::YFP expression in the pharynx.
RESULTS
ClusterSearch, a computational program to
perform genome-wide searches of evolutionarily
conserved regulatory elements
To carry out a genome-wide search for genes co-expressed from a
common regulatory element consisting of multiple binding sites of
sequence-specific DNA-binding proteins, we developed a
computational program (ClusterSearch) that identifies orthologous
genes sharing a defined regulatory element in the annotated genome
sequences of C. elegans and C. briggsae. We imported the genomic
DNA sequences of C. elegans and C. briggsae in the FASTA format
and their annotation data (gene names, orthology tables, positions of
transcriptional initiation sites, exons and introns) in the GFF format
from WormBase (http://www.wormbase.org). The program
simultaneously scans both genome sequences for the locations of











defined regulatory elements (binding sites of multiple transcription
factors) in a fixed base-pair window. It then summarizes the search
results using orthology tables to identify the orthologous genes
predicted to have common regulatory elements. Output is displayed
in a window listing a variety of information on each match,
including chromosomal location, gene name, ortholog name,
distances to the first and the closest exons, and the sequence that
contains the conserved regulatory elements.
The program, which includes an in-depth description, user
manual, tutorial and quick-start installation guide, is available at
http://sourceforge.net/projects/clustersearch. We used version 1.0b1
in this study.
Identification of egl-43 as a gene co-expressed
with lin-3 in the pre-AC/pre-VU and the AC
We had previously identified a 59 bp enhancer in the C. elegans lin-
3 gene (ACEL, Anchor Cell-specific Enhancer of LIN-3) that directs
its expression in the AC (Hwang and Sternberg, 2004). This element
comprises two E boxes and one FtzF1 NHR binding site. Here, we
show that this ACEL element is sufficient to express GFP in the pre-
AC/pre-VU cells. Site-directed mutagenesis of the E-boxes or FtzF1
NHR binding site, but not those of other regions, eliminates GFP
expression in both pre-AC/pre-VU and AC cells (Fig. 1). Thus, the
same trans-acting factors (including HLH-2 that binds to the E boxes
in the ACEL enhancer and is required for LIN-3 expression in the
AC) (Hwang and Sternberg, 2004) appear to be responsible for LIN-
3 expression in the pre-AC/pre-VU cells before AC/VU cell-fate
specification. Since hlh-2 but not lin-3 is involved in the AC/VU
specification (Karp and Greenwald, 2003), this finding also suggests
that other genes expressed from the ACEL-like elements are likely
to play important roles during the AC/VU specification process.
To identify genes co-expressed with lin-3 from the ACEL-like
elements, we used the ClusterSearch program to identify
orthologous genes in the C. elegans and C. briggsae genomes that
contain more than two E-boxes (CANNTG, where N specifies
any nucleotide) and one FtzF1 NHR binding site
[CA(A|G)GG(A|T|C)(C|T)] within a 100 base-pair window. Among
the 35 orthologs that contain the predicted ACEL-like elements in
the 5-regulatory, first and second intronic regions, we further
analyzed the six candidate genes (nhr-22, nhr-25, nhr-91, egl-43,
egl-46 and F52F12.6) that have predicted DNA-binding domains.
We examined the AC-related phenotypes in worms where RNAi
blocked the expression of the six candidate genes; we measured
AC/VU specification, AC-specific lin-3 expression, VPC induction
and AC invasion. RNAi against two candidates, egl-43 and nhr-25,
caused defective phenotypes. nhr-25 RNAi-treated animals showed
defective proliferation of VPCs, which could be due to loss of
expression in the AC or vulval cells. nhr-25 has been shown to be
expressed in the pre-AC/pre-VU, AC and vulval cells
(Gissendanner and Sluder, 2000). NHR-25 binds to the wild-type
FtzF1 NHR binding site, but not to the site containing the lin-
3(e1417) mutation, in the ACEL element (Hwang and Sternberg,
2004). egl-43 RNAi caused defects in AC/VU specification and AC
invasion, but not in AC-specific lin-3 expression and VPC induction
(Fig. 2).
EGL-43 is involved in LIN-12 (Notch)-dependent
AC/VU cell fate specification and in anchor cell
invasion
When egl-43 expression was blocked by soaking L1 animals in
dsRNA, 78% (63 of 81) of the animals containing AC-specific
markers (lin-3::GFP or cdh-3::GFP) (Hwang and Sternberg, 2004;
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Table 1. Sequences of DNA probes and competitors used for the EMSA with HLH-2 and LAG-1
EMSA with HLH-2
DNA probe containing wild-type E-boxes
gaattcaaaaattccttaCACCTGtctttccacctttcccgctccccccgtccattaccactttgttaaccttgggggcacactagtaaccattacattaggattt-
acaaatcggaaCACCTGgtgccttggtgaattc
DNA probe containing mutated E-boxes
gaattcaaaaattccttaCTCCTAtctttccacctttcccgctccccccgtccattaccactttgttaaccttgggggcacactagtaaccattacattaggattt-
acaaatcggaaCTCCTAgtgccttggtgaattc
Wild-type competitor DNAs Mutated competitor DNAs
1st: aaattccttaCACCTGtctttccacc 1st: aaattccttaCTCCTAtctttccacc
2nd: caaatcggaaCACCTGgtgccttggt 2nd: caaatcggaaCTCCTAgtgccttggt
EMSA with LAG-1
DNA probe containing wild-type LAG-1 binding sites
gaattctcgcgactCGTGGGAAaatgggcggaagggcacCGTGGGAAaatagttccaggaattc
Wild-type competitor DNAs Mutated competitor DNAs
1st: taataatctctTCCCAaactacacctc 1st: taataatctctAACCAaactacacctc
2nd: cctaactcctaTCCCAaattcgtacat 2nd: cctaactcctaAACCAaattcgtacat
3rd: ttcttgtttctTCCCAcgtacagtttc 3rd: ttcttgtttctAACCAcgtacagtttc
4th: ttacaaattctTCCCAgaacccaaaac 4th: ttacaaattctAACCAgaacccaaaac
5th: gggatccgagaTGGGAaaagagactcg 5th: gggatccgagaTGGTTaaagagactcg
6th: acagtcgctgaTGGGAaaatggataat 6th: acagtcgctgaTGGTTaaatggataat
7th: tgctctcacagTGGGAaaattagattc 7th: tgctctcacagTGGTTaaattagattc
8th: gcgaagatctgTGGGAaaatatacaga 8th: gcgaagatctgTGGTTaaatatacaga
Sequences of DNA probes for HLH-2 and competitors for HLH-2 and LAG-1 (see Fig. 6) from the C. elegans egl-43 gene. The DNA probe sequence for LAG-1 EMSA has been
used for EMSA with CBF-1 and Su(H) proteins, mammalian and D. melanogaster orthologs of LAG-1 (Zimber-Strobl et al., 1994). Sequences of the upper strand of DNA












Pettitt et al., 1996) had at least two ACs expressing GFP at L3 (Fig.
2A-D). Since cdh-3::GFP is expressed in the AC but not in the pre-
AC/pre-VU cells, the lack of egl-43 expression appears to change
presumptive VU cells into ACs rather than arresting the
development of pre-AC/pre-VU cells. There is no predicted
secondary target for egl-43 RNAi in the C. elegans genome
(http://www.wormbase.org). Furthermore, dsRNAs against different
regions of egl-43 (cDNA sequences corresponding to exons 1 to 5,
exons 7 to 10, and exons 1 to 10) were equally potent in causing the
multiple AC defect (data not shown). In control RNAi experiments
with 46 genes (see Materials and methods), only three out of ~900
animals examined showed two ACs, suggesting the high precision
of the AC/VU cell fate specification process and the specific role of
EGL-43 in this process.
Multiple ACs in C. elegans hermaphrodites have largely been
observed in mutant animals (allele n137) in which molecules
involved in LIN-12 (Notch) signaling (Greenwald, 2005), or in the
early-stage asymmetric division of somatic gonadal cells along the
proximal-distal axes (sys-1 to sys-3, gon-14 to gon-16 mutants)
(Siegfried et al., 2004), become defective. These sys and gon mutant
hermaphrodites, in contrast to those defective in LIN-12 signaling,
have a loss or decreased number of distal tip cells (DTCs) owing to
the loss of gonad asymmetry (Miskowski et al., 2001; Siegfried et
al., 2004; Siegfried and Kimble, 2002). We found that egl-43 RNAi
(n=26) did not alter the number of DTCs as compared with the
control RNAi (n=23), in which each hermaphrodite contains one
DTC in each gonad arm (Fig. 2E,F). Furthermore, the extra ACs are
separated in these sys and gon mutants, but are clustered in the
mutants involved in the LIN-12 signaling as well as in the animals
treated with egl-43 RNAi. Thus, egl-43 appears to work closely with
LIN-12 signaling, but not with the Wnt and MAP kinase signaling
involved in the asymmetric division of somatic gonadal cells
(Siegfried et al., 2004).
Elimination of egl-43 expression reverses the AC-deficient
phenotype of lin-12 (gain-of-function) mutant animals; egl-43 RNAi
(61%, 44 of 61), but not control RNAi (0 of 26), resulted in lin-
12(n137) animals with multiple cdh-3::GFP expressing ACs (Fig.
2G,H). Thus, egl-43 acts downstream of or in parallel to lin-12
during AC/VU specification.
AC invasion was defective in 65% (96 of 147) of animals treated
with egl-43 RNAi as judged by the lack of contact between the AC
and the P6.p descendants visible under Nomarski optics (Fig. 2J,L).
All animals (66) treated with control RNAi had attachment of the
AC to the underlying P6.p descendants (Fig. 2I,K). When AC
invasion was visualized with cytoplasmic GFP (cdh-3::GFP), the
invasion defect was evident in the egl-43 RNAi-treated animals: cdh-
3::GFP in the AC was distinct from that in vulval cells (vulC, D, E
and F), and the AC neither crossed the basement membranes nor
penetrated the central 1°-fated vulval cells (Fig. 2I-L). In addition,
when the specific breakdown of the basement membranes at the site
of AC contact was examined using a basement membrane marker
(sparc::GFP), 46% (27 of 58) of animals treated with egl-43 RNAi
had intact membranes, but none (0 of 19) treated with control RNAi
did (Fig. 2M,N).
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Fig. 1. Characterization of the
enhancer that drives LIN-3
expression in the pre-AC/pre-VU
and AC. (A) In wild-type animals,
Z1.ppa and Z4.aap cells always
become VU cells and Z1.ppp and
Z4.aaa cells have equal potential to
become the AC or a VU. (B-D) In
wild-type animals, LIN-3::GFP is
expressed (B) in the pre-AC/pre-VU
cells before AC/VU specification and
(C) in the AC after the specification.
Multiple gonadal cells express LIN-
3::GFP after specification in the lin-
12 (null) background (D). LIN-3::GFP
is not expressed in any gonadal cells
of the lin-12 (gain-of-function)
animals after mid-L2 stage where all
four pre-AC/pre-VU cells are
transformed into VU cells (data not
shown). (E) Anchor Cell-specific
Enhancer of LIN-3 (ACEL) is sufficient
to express GFP in both AC and pre-
AC/pre-VU cells. Site-directed
mutations of the E-boxes or FtzF1
NHR binding site, but not those in
other regions, eliminate GFP
expression in both cell types.
Expression of these constructs in the












Although most animals treated with egl-43 RNAi show defects
in both AC/VU specification and AC invasion, the formation of
multiple ACs does not appear to be tightly linked to defective AC
invasion because egl-43 RNAi sometimes causes a defect in either
cell fate specification or the invasion (data not shown).
Furthermore, PR-YFP, a putative dominant-negative form of EGL-
43, causes a defect in the invasion but not in AC/VU specification
(see Fig. 5).
We observed embryonic-lethality in homozygotes of the null
mutant egl-43(tm1802). Both specification and invasion were
normal in the egl-43(tm1802)/+ heterozygote and in the
homozygotes of the egl-43 mutants (n997 and n1079) (data not
shown) in which the deletion of its 3-regulatory region specifically
eliminates EGL-43 expression in the HSN neurons (Garriga et al.,
1993).
EGL-43 is expressed in the AC, VU and DU lineages
in the hermaphrodite gonad
The L2 stage of the hermaphrodite somatic gonad is an amitotic
stage in which all 12 somatic gonadal cells stop dividing, the
proximal 10 cells rearrange, and one of them, the presumptive AC
(pre-AC), moves into the mid-sagittal plane on the ventral surface of
the gonad (Hirsh et al., 1976; Kimble and Hirsh, 1979). In our study,
we divide the L2 stage into three sub-stages (early, mid and late)
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Fig. 2. EGL-43 is required for AC/VU specification and AC invasion. Images of the gonad and vulva region of hermaphrodites in the mid-L3 (2
and 4-cell P6.p stage; A-F,I,J) and the early L4 (8-cell P6.p stage; G,H,K-N) stages. (A-H) Nomarski (left), fluorescence (right) and overlay (center). (I-
N) Nomarski (top), fluorescence (bottom) and overlay (middle). Transgenic animals that contain (A,B) lin-3::GFP (syIs107, for the AC), (C,D) cdh-
3::GFP (syIs50, for the AC), (E,F) lag-2::YFP (syIs128, for the DTC), or (M-N) sparc::GFP (syIs113, for the basement membrane) were soaked in the
control or egl-43 dsRNA solution. (G) In control RNAi-treated animals that carry a gain-of-function mutation (n137) of lin-12, the AC is transformed
into a VU cell. Additional vulval cells (Muv phenotype) express cdh-3::GFP (green) at early L4. (H) In animals treated with egl-43 RNAi, two ACs
expressing cdh-3::GFP (green, arrows) are present owing to the suppression of activated LIN-12 during AC/VU specification. However, egl-43 RNAi
does not suppress the Muv phenotype caused by the activated LIN-12. (I) With control RNAi, the basement membranes are interrupted (between
the arrowheads) underneath the AC (expressing cdh-3::GFP in white), and the basolateral side of the AC crosses through the hole in the basement
membranes and penetrates between central 1°-fated vulval cells. (J) In animals treated with egl-43 RNAi, two partially overlapping ACs (expressing
cdh-3::GFP in white) cannot cross the unbroken basement membranes. A distinct line representing the juxtaposed gonadal and ventral epidermal
basement membranes is visible under Nomarski optics, separating the AC from the P6.p granddaughters. (K) The basolateral portion of the AC
invades between the central P6.pap and P6.ppa cells. Because some vulval cells also express cdh-3:GFP at early L4, the cytoplasmic GFP signals in
the AC (arrow) and vulval cells overlap. (L) In animals treated with egl-43 RNAi, the GFP signal in the ACs is separated from those in the vulval cells
because the ACs (arrows) could not invade into the vulval epithelium. The basement membranes between gonad and vulval epithelium are (N)












(Fig. 4A). In the early stage, soon after the pre-AC/pre-VU cells are
born from their parents (Z1.pp and Z4.aa) at L1 molt, neither of the
Z1.ppp and Z4.aaa cells that have equal potential to become the AC
has yet moved to the central position in the gonad. In mid-L2, either
the Z1.ppp or the Z4.aaa cell is moving or has moved to the central
position on the ventral surface of the gonad. Thus, the AC is
visualized at a focal plane different from those of the three VU cells.
In late L2 animals, cdh-3::CFP signal can be detected in the AC
after it has moved to the central position.
Deletion analysis of the egl-43 genomic region using a YFP
reporter identified the 5 and the first intronic regions as being
necessary for its expression in the hermaphrodite somatic gonad,
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Fig. 3. Site-directed mutagenesis of E-boxes of the ACEL-like element and LAG-1 binding sites in egl-43. (A) egl-43 gene structure. The
ACEL-like element that contains two E-boxes is predicted in the first intron, and eight LAG-1 binding sites are predicted in the 5 regulatory and the
first intronic regions. (B,C) egl-43 (wild type)::YFP is expressed (green) at early L2 in the pre-AC/pre-VU cells located in two different focal planes.
(D,E) Either the Z1.ppp or Z4.aaa cell moves to the central position on the ventral surface of the gonad to become the AC (green, arrow), which is
located (D) in a focal plane different from the two focal planes containing the three VU cells (green). Only one VU focal plane is shown in E.
(F,G) The AC begins to express cdh-3::CFP at late L2. The AC (arrow) is appears yellow in F because of the co-localization of cdh-3::CFP (red) and
egl-43::YFP (green). (H,I) The egl-43 (mutated E-boxes)::YFP is not expressed in the pre-AC/pre-VU cells, AC and VU cells until late L2. (J,K) egl-43
(mutated E-boxes)::YFP is expressed in the three VU cells (green), and not in the AC (arrow), when the cdh-3::CFP begins to be expressed in the AC
(J, red) at late L2. (L-Q) The egl-43 (mutated LAG-1 sites)::YFP is expressed in the pre-AC/pre-VU cells at early L2 (L,M, green). One cell (Z4.aap)
expresses YFP very weakly in this animal (L). At mid-L2, YFP expression is retained in the AC (N, in green, arrow), but is lost or decreased in the VU
cells (O). At late L2 when the cdh-3::CFP (red) begins to be expressed in the AC (P, arrow), three VU cells regain the YFP signal (Q). The AC expresses
both cdh-3::CFP (red) and egl-43 (mutated LAG-1 sites)::YFP (green) at this stage, resulting in the merged yellow colour (P). The egl-43 (mutated
LAG-1 sites)::YFP (green) begins to be expressed in two DU cells (yellow arrow) right after the three VU cells regain YFP expression (Q). Only one VU
focal plane is shown. For each construct, about 100 animals were examined from six to ten transgenic lines. The pictures represent typical
expression patterns at specific stages. The lines include syEx895 and syEx896 for the wild type; syEx891 and syEx892 for the mutated E-boxes;











which is consistent with a previous report that EGL-43 is expressed
in some somatic gonadal cells (Baum et al., 1999). This region
contains the predicted ACEL-like element and a cluster of eight
LAG-1 binding sites (Fig. 3A). egl-43::YFP expression in the gonad
was first detected in the pre-AC/pre-VU cells at early L2 (Fig.
3B,C), and was maintained in their 37 descendants at early L4. egl-
43::YFP was also expressed in the AC and VU cells when their cell
fates become specified at mid-L2 (Fig. 3D,E). Expression in the two
dorsal uterine precursor (DU) cells (Z1.pap and Z4.apa) was first
detected at late L2 (data not shown) and was maintained in their
descendants. Thus, egl-43 is expressed in the AC, VU and DU
lineages in the somatic gonad.
Alternative transcriptional initiations in egl-43 produce two
transcripts ( and ) that encode different sizes of in-frame proteins
(Garriga et al., 1993). The  form contains only the C-terminal
portion of the  form, whose translational initiation was predicted
from the ATG codon in the sixth exon. To determine whether these
transcripts are differentially transcribed, we generated an egl-43
genomic construct that contains an HA-epitope after the ATG in the
first exon, and GFP after the ATG in the sixth exon. Transgenic
animals expressing the HA-GFP double tags were then stained with
anti-HA antibodies to monitor the expression of the  form, and with
anti-GFP antibodies to monitor the expression of both  and 
forms. This double labeling experiment indicated that the two
transcripts are not differentially expressed, as evidenced by their
identical cellular and temporal expression pattern (data not shown).
Multiple regulatory elements are responsible for
the temporally dynamic expression of egl-43
We predicted that egl-43 would be co-expressed with lin-3 because
they share the same type of enhancer (ACEL), which comprises two
E-boxes (‘CACCTG’ form) and one FtzF1 NHR binding site
(Hwang and Sternberg, 2004). Site-directed mutagenesis studies
indicate that both E-boxes in the ACEL-like element are necessary
to express egl-43::YFP in the four pre-AC/pre-VUs and the AC (Figs
3 and 4). These E-boxes are also necessary to express egl-43 in the
pre-VU cells undergoing the specification because their mutation
eliminates the egl-43::YFP expression until late L2 (Figs 3 and 4).
Since HLH-2 directly binds to the E-boxes in the ACEL-like region
in egl-43 (Fig. 6C,D), the requirement of E-boxes for egl-43
expression in the pre-VU cells suggests that egl-43 is involved in the
specification of VU fate as a direct target of HLH-2. We could not
directly address the involvement of HLH-2 in the egl-43 expression
in these pre-AC/pre-VU cells because of the profound effects of the
hlh-2 RNAi on the development of the somatic gonad prior to
AC/VU specification (Karp and Greenwald, 2003; Karp and
Greenwald, 2004).
A cluster of eight predicted LAG-1 binding sites (‘TGGGA’)
(Christensen et al., 1996) surrounds the ACEL-like element in egl-
43 (Fig. 3A), suggesting a possible interaction between these two
regulatory motifs. LAG-1 binds to all of the predicted sites but with
different affinities in vitro (Fig. 6A,B). To investigate whether this
region of clustered LAG-1 binding sites is a direct target of LIN-12
signaling in vivo, we carried out chromatin immunoprecipitation
(ChIP) assays (Fig. 6E). C. elegans Notch signaling is mediated by
a ternary complex containing the SEL-8 (LAG-3) transcriptional co-
activator, LAG-1, and the intracellular domain of Notch (Petcherski
and Kimble, 2000). To detect specific DNA sequences bound to this
complex in vivo, we immunoprecipitated SEL-8 in the cellular
lysates that contain chromatin DNA fragments from the animals
expressing SEL-8::GFP and performed PCR to detect the
enrichment of specific DNA sequences in the precipitate (Lee et al.,
2006). This ChIP experiment showed that the regions containing
LAG-1 binding sites [egl-43 (1) and lip-1], but not the region lacking
the LAG-1 binding sites [egl-43 (2)], are enriched in the precipitates
with anti-LAG-3 (SEL-8) and anti-GFP antibodies as compared with
those with the control IgG and anti-HLH-2 antibodies (Fig. 6E). lip-
1 is more enriched than egl-43 in the precipitates, probably because
lip-1 is more broadly or abundantly expressed than egl-43 as a
consequence of its broad expression in germline cells. In this ChIP
experiment, we could not detect an interaction between the E-boxes
in the ACEL-like region and HLH-2 in vivo, which might reflect the
technical difficulties in detecting in vivo protein-DNA complexes
when transcription factors are expressed at low levels and in few
cells.
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Fig. 4. Multiple regulatory elements are required for EGL-43
expression in the AC, DU and VU lineages. (A) Results of the site-
directed mutagenesis study and fos-1 RNAi are summarized. White
areas represent the absence of egl-43::YFP expression. Green areas
represent the presence of YFP expression at specific developmental
stages. The areas marked in light green represent decreased egl-43::YFP
expression. (B) Model summarizing egl-43::YFP expression patterns in
the somatic gonad. The ACEL-like element containing two E-boxes is
the major enhancer expressing EGL-43 in the pre-AC/pre-VU cells and
in the AC, but not in the VU cells. LAG-1 binding sites are also required
for EGL-43 expression in the pre-VU cells when AC/VU cell fates
become specified. Unidentified enhancers increase EGL-43 expression in













To determine the effects of the LAG-1 binding sites on egl-43
expression, we mutated the LAG-1 binding sites in the egl-43::YFP
construct (see Fig. S1 in the supplementary material) and examined
the somatic gonadal expression pattern of individual animals at
different stages (Fig. 3L-Q, Fig. 4). Site-directed mutation of the
LAG-1 binding sites did not eliminate egl-43::YFP expression in the
pre-AC/pre-VU cells and the AC (Fig. 3L-N). However, it
eliminated or variably reduced YFP expression in the pre-VU or VU
cells at mid-L2 after specification of the AC/VU cell fates (Fig. 3O).
Thus, the LAG-1 binding sites appear to be necessary to maintain
egl-43 expression in the pre-VU or VU cells during AC/VU
specification. We could not directly address the involvement of lag-
1 and lin-12 in the egl-43 expression in the VU cells because of the
cell fate transformation of VU cells into the ACs upon eliminating
lag-1 and lin-12 expression by mutation or RNAi. Since E-boxes in
the ACEL-like element are also necessary for the egl-43 expression
in the pre-VU cells, interaction between the LAG-1 cluster and the
ACEL-like element is likely to allow egl-43 expression in pre-VU
and VU cells during the specification process. The interaction
between a LAG-1/Su(H) cluster and E-boxes appears to be
evolutionarily conserved, as seen in the regulation of Enhancer of
split [E(spl)] complex genes during specification of sensory organ
precursor cell fates in Drosophila peripheral neurogenesis (Castro
et al., 2005).
Although LAG-1 binding sites and E-boxes are necessary for egl-
43 expression during AC/VU specification, other unidentified
elements appear to support egl-43 expression in the AC from mid-
L3 when P6.p daughters begin to divide (Fig. 5C,D), and also in the
VU, DU and their descendants from late L2 after AC/VU
specification (Figs 3 and 4). This late-stage egl-43 expression in the
AC, DU and VU cells was affected neither by mutating E-boxes in
the ACEL-like element or the LAG-1 binding sites, nor by treating
animals with lag-1 RNAi (data not shown), which rules out the
involvement of cryptic LAG-1 binding sites for the late-stage egl-43
expression in these cells. These late-stage enhancers appear to be
responsible for the higher level of egl-43 expression at L3 (Fig. 5O-
R), which may be necessary for AC invasion and perhaps also for
the patterned proliferation of VU cells. The variable decrease in elg-
43 expression caused by mutating the LAG-1 binding sites could be
due to the presence of a LAG-1-independent late-stage VU enhancer
that strongly drives egl-43 expression from late L2 after AC/VU
specification.
The early-stage expression of EGL-43 in somatic
gonad appears to be necessary for AC invasion
To determine when EGL-43 is necessary for the AC invasion, we
expressed the amino-terminal domain of EGL-43 (PR domain)
(Moore et al., 2002) fused with YFP, which allowed us to monitor
both expression and phenotypes. We expected this PR domain-YFP
protein to be a dominant-negative form of EGL-43 because the PR
domain regulates the oligomerization of the EVI1 protein (Nitta et
al., 2005), and EVI1 protein variants lacking the PR domain can
cause leukemia (Fears et al., 1996; Morishita et al., 1988). AC
invasion was defective (60%, 26 of 43) when PR-YFP expression
was driven by the wild-type regulatory region of egl-43 (Fig. 5E).
This construct expresses the fusion protein in the VU and DU
lineages as well as in the AC from early L2 (Fig. 3, Fig. 4, Fig.
5A,B). By contrast, AC invasion was normal (50 out of 50) when the
PR-YFP protein was expressed using the region containing mutated
E-boxes (Fig. 5F) that eliminates the early expression in the AC and
VU lineage (Fig. 4, Fig. 5C,D). Thus, the early-stage expression of
EGL-43 in these somatic gonadal cells appears to be necessary for
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Fig. 5. EGL-43 is involved in AC invasion as a downstream target of HLH-2 and FOS-1. Animals containing cdh-3::CFP (red) were injected
with egl-43 (PR-domain)::YFP constructs. (A-F) The PR-YFP transgene is expressed (green) in the VU and DU lineages as well as in the AC from early
L2 when using the wild-type egl-43 regulatory region (A,B), and shows the AC (cdh-3::CFP, white) invasion defect (E). The transgene is expressed in
the VU and DU lineages from late L2, but in the AC from mid-L3, when using the mutated E-boxes (C,D), and shows normal AC invasion (F).
(G-L) egl-43 RNAi eliminates expression of zmp-1::GFP (G,H) and him-4::GFP (I,J) in the AC (arrow), but not of fos-1::YFP (K,L). egl-43 RNAi resulted
in two ACs in which fos-1::YFP is expressed higher than in the neighboring gonadal cells (L, arrows). (M-R) fos-1 RNAi greatly reduces egl-43
expression in the AC, and in the DU and VU descendants at the L3 molt (M,N) and at mid-L3 (Q,R), but not at mid-L2 (O,P). Animals from a











invasion. The invasion defect caused by expressing PR-YFP (Fig. 5)
appears identical to that caused by egl-43 RNAi (Fig. 2). Since
HLH-2 is required for inducing VPCs, we could not directly
examine the role of HLH-2 in AC invasion because this process
requires the presence of the vulva (Sherwood and Sternberg, 2003).
However, both E-boxes in egl-43 are necessary for its expression in
the AC and for AC invasion.
egl-43 is a late-stage-specific downstream target
of FOS-1 during AC invasion
To identify genes that interact with egl-43 during AC invasion, we
analyzed the expression of genes previously implicated in the
invasion (Sherwood et al., 2005); more than 30 animals were
examined for each transgene. egl-43 RNAi did not greatly alter AC
expression of cdh-3::GFP and fos-1::YFP (Fig. 5K,L), but severely
reduced AC expression of zmp-1 and him-4 (hemicentin) (Fig. 5G-
J). Since egl-43 appears to be upstream of zmp-1 and him-4, but not
of fos-1, we tested whether fos-1 is an upstream of egl-43. Indeed,
fos-1 RNAi eliminated egl-43::YFP expression in the DU and VU
descendants as well as in the AC (Fig. 5M,N), suggesting that fos-1
is an upstream regulator of egl-43 in these gonadal cells. Since
unknown late-stage enhancers are responsible for upregulating egl-
43 expression in these cells (Figs 3 and 4), we tested whether egl-43
expression is sensitive to fos-1 RNAi at specific stages and found
that fos-1 RNAi does not decrease egl-43 expression at L2 during
AC/VU specification (Fig. 4A, Fig. 5O,P). This finding is consistent
with the fact that fos-1 is not involved in AC/VU specification
(Sherwood et al., 2005), and also suggests that egl-43 is a late-stage-
specific (from L3) downstream target of FOS-1 during AC invasion.
DISCUSSION
In this paper, we computationally identified egl-43 as a gene co-
expressed with lin-3 in the pre-AC/pre-VU cells and in the AC. In
addition to this predicted regulatory element in egl-43, additional
elements including a cluster of LAG-1 binding sites and a FOS-1
responsive element drive egl-43 expression for proper AC/VU
specification and AC invasion. Although there are many possible
mechanisms through which EGL-43 regulates two different cellular
events, we favor the model that different expression levels of EGL-
43 could regulate the expression of different sets of genes. For
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Fig. 6. HLH-2 and LAG-1 bind to egl-43 regulatory regions. (A,B) EMSA with in vitro translated (TNT) LAG-1. Shifted complexes (B1 and B2)
appear in the presence of LAG-1. The binding complexes are competed by DNAs containing the wild-type (w) but not the mutated (m) LAG-1
binding sites. ‘F’ indicates the migration of the free DNA probe. (C,D) EMSA with purified HLH-2. A shifted complex ‘B’ appears with HLH-2 and the
wild-type ACEL-like probe, but not with Luciferase or with the probe on which both E-boxes are mutated. (D) The binding complex is competed by
DNAs containing the wild-type (w) but not the mutated (m) E-boxes. DNA sequences are listed in Table 1; the numbers in B and D correspond to
those of DNA competitors in Table 1. (E) PCR analysis from ChIPs performed with the extracts from animals expressing SEL-8::GFP. Pre-IP represents
the input extracts subjected to IP. The 5-region of lip-1, which contains four LAG-1 binding sites and was shown to be immunoprecipitated with












AC/VU specification, a low level of EGL-43 expression is supported
by HLH-2, LAG-1 and LIN-12, and for AC invasion, a higher level
of EGL-43 expression is provided by the addition of FOS-1 and
other unidentified factors. However, an equally plausible model is
that different sets of genes interact with egl-43 during two different
cellular processes.
We observed egl-43::YFP expression in the Z1.pp and Z4.aa cells
in some transgenic lines, suggesting its weak expression in these
cells. By contrast, YFP is consistently expressed in their daughter
cells in all transgenic lines of the egl-43 (wild-type)::YFP construct
examined. It is possible that we could not detect a difference in egl-
43::YFP expression between the pre-AC and the pre-VU cells
because of the long half-life (longer than 12 hours) of YFP protein
and the presence of multiple temporally active regulatory elements
that support the dynamic egl-43 expression in these cells and their
descendants at L2 and L3 (Figs 3 and 4). Since E-boxes are required
for egl-43 expression in these cells during AC/VU specification
(Figs 3 and 4), and because the pre-AC contains higher amounts of
HLH-2 protein than do pre-VU cells (Karp and Greenwald, 2003;
Karp and Greenwald, 2004), the pre-AC could contain transiently
higher amounts of EGL-43 than pre-VU cells. However, it is also
possible that the cluster of LAG-1 binding sites is responsible for
higher EGL-43 expression in the pre-VU cells than in the pre-AC.
Unfortunately, the long half-life of YFP prevented us from
measuring any difference in egl-43 transcription during the
specification process. Destabilized YFP expression derived by the
egl-43 regulatory region was not strong enough for us to detect (data
not shown). However, considering the HLH-2 expression pattern (its
specific disappearance in the VU cells), and the nature of the LAG-
1 cluster that expresses genes in the pre-VU or VU cells during the
specification process, we speculate that EGL-43 is differentially
expressed between pre-AC and pre-VU cells during AC/VU
specification.
Other than basic helix-loop-helix (bHLH) proteins of the
Hairy/E(spl) family (Bailey and Posakony, 1995; Jarriault et al.,
1995; Neves and Priess, 2005), the zinc-finger protein EGL-43
represents the only known direct downstream transcription factor of
Notch involved in cell fate specification. Elimination of egl-43, hlh-
2, lag-1 or lin-12 expression results in extra ACs, suggesting that
these genes are necessary to specify the VU cell fate, and failure of
this specification results in the pre-VU cells adopting the default AC
fate (Seydoux and Greenwald, 1989). This model is supported by
our finding that egl-43 is a downstream target of HLH-2 and LAG-
1/LIN-12 in the pre-VU cells, as indicated by genetic epistasis
analysis, characterization of the regulatory elements in egl-43, and
DNA-binding experiments.
Although EGL-43 is necessary for both the migration of HSN
neurons and AC invasion, most of the other genes involved in HSN
migration do not appear to be involved in AC invasion (Garriga and
Stern, 1994). RNAi against 14 out of 16 genes involved in HSN
migration did not cause a defect in AC invasion (data not shown),
suggesting that the AC invasion mechanism is different from the
mechanism through which the neuronal cell body migrates at long
distance.
Two lines of evidence suggest that EGL-43 is an indirect
downstream target of FOS-1. First, DNA-binding consensus
sequences of mammalian Fos proto-oncogenes (‘TGACTCA’) do not
exist in the regulatory region of egl-43, which is sufficient to express
egl-43::YFP in the somatic gonadal cells in a FOS-1-dependent
manner. Second, ChIP analysis to measure the binding of FOS-1::GFP
protein on the egl-43 regulatory region could not identify any direct
physical interaction between FOS-1::GFP and the egl-43 regulatory
region in the evl-5 animals in which the defects of fertility and AC
invasion were rescued by the expression of fos-1::GFP (data not
shown). Since EVI1, the mammalian ortholog of EGL-43, is a
transcriptional repressor (Bartholomew et al., 1997; Perkins et al.,
1991), we speculate that egl-43 is an indirect upstream factor of zmp-
1 and him-4. Thus, along with the identification of the downstream
factor(s) of FOS-1, which activates egl-43 expression during AC
invasion, identification of the EGL-43 direct downstream factor(s) that
activates zmp-1 and him-4 in the AC will be an important step to
understanding the regulatory network that regulates AC invasion.
HLH-2 is required for LAG-2 expression during AC/VU
specification (Karp and Greenwald, 2003), and LIN-3 expression is
required for vulval induction (Hwang and Sternberg, 2004). We
show that HLH-2 is necessary for EGL-43 expression, along with
LIN-12/LAG-1 during AC/VU specification and with FOS-1 during
AC invasion (Fig. 7). Combining these results, we conclude that two
cellular events following AC/VU specification, induction of vulval
precursor cell proliferation and anchor cell invasion, are initiated by
factors involved in AC/VU specification, HLH-2 and EGL-43.
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Fig. 7. EGL-43 and HLH-2 are
required for AC/VU specification,
VPC proliferation and AC
invasion. (A) egl-43, fos-1, him-4,
hlh-2 and zmp-1 form a regulatory
network necessary for the AC to
invade vulval epithelium. (B) hlh-2 is
involved in AC/VU specification by
expressing lag-2 and egl-43. The
same type of enhancer (ACEL) is
responsible for the expression of lin-3
and egl-43 in the AC, which are













Supplementary material for this article is available at
http://dev.biologists.org/cgi/content/full/134/4/669
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